Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Fellowship - Priority Announcement - Inflammatory Bowel Disease

University of Toronto

$45,000.00

Relative roles of Nod1 and Nod2 in specific cell types during intestinal inflammation.

FY 2011-12

Summary
Inflammatory Bowel Disease (IBD) is a lifelong, chronic condition marked by debilitating flare-ups of inflammation in the gastrointestinal tract of which the causes are unknown and there is no cure. Recently, however, research has made significant strides towards understanding the mechanisms behind this disease, particularly through the use of studies that scan and compare the entire genomes of patients with IBD versus healthy patients to identify variations of genes that can lead to greater susceptibility to the disease. A vast majority of these genes seem to be involved in the recognition and response to bacterial infection, which supports the hypothesis that IBD arises as the result of a dysfunctional immune response to the vast numbers of harmless bacteria that line the surface of the gastrointestinal tract. Two of the first genes identified were Nod1 and Nod2, which are both responsible for detecting peptidoglycan, a component of the coating that surrounds individual bacteria cells. It is known that mutations in Nod1 and Nod2 that make an individual more likely to develop IBD result in these genes functioning at a sub-optimal level, but how this ultimately leads to IBD remains unknown. This goal of this project is therefore to identify the specific cell types in which Nod1 and Nod2 are active in order to better understand their role in intestinal inflammation. We will use state of the art techniques to selectively block the expression of either Nod1 or Nod2 in a mouse for each cell type. These mice will then be subjected to either experimental intestinal inflammation or infection with an intestinal pathogen such as Salmonella typhimurium. By doing this, we will be able to better understand exactly what the functions Nod1 and Nod2 have in the intestine, how the loss of these functions can lead to IBD, and ultimately what we can do to target Nod1 and Nod2 function therapeutically to treat or cure patients with IBD.
Program
Fellowship - Priority Announcement - Inflammatory Bowel Disease
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
243163
Name
Prescott David
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Canadian Association of Gastroenterology (Oakville, Ontario); Crohn's and Colitis Canada (Toronto, Ontario)
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Relative roles of Nod1 and Nod2 in specific cell types during intestinal inflammation.
Programtype2
Fellowship Programs
Orgnameinp2
University of Toronto
Cihramount2
$45,000
Cihrequipment2
$0
Programname2
Fellowship - Priority Announcement - Inflammatory Bowel Disease
Keyworddelim
Host Defense; Infection; Inflammation; Inflammatory Bowel Disease; Innate Immunity; Nod1/Nod2
Abstract
Inflammatory Bowel Disease (IBD) is a lifelong, chronic condition marked by debilitating flare-ups of inflammation in the gastrointestinal tract of which the causes are unknown and there is no cure. Recently, however, research has made significant strides towards understanding the mechanisms behind this disease, particularly through the use of studies that scan and compare the entire genomes of patients with IBD versus healthy patients to identify variations of genes that can lead to greater susceptibility to the disease. A vast majority of these genes seem to be involved in the recognition and response to bacterial infection, which supports the hypothesis that IBD arises as the result of a dysfunctional immune response to the vast numbers of harmless bacteria that line the surface of the gastrointestinal tract. Two of the first genes identified were Nod1 and Nod2, which are both responsible for detecting peptidoglycan, a component of the coating that surrounds individual bacteria cells. It is known that mutations in Nod1 and Nod2 that make an individual more likely to develop IBD result in these genes functioning at a sub-optimal level, but how this ultimately leads to IBD remains unknown. This goal of this project is therefore to identify the specific cell types in which Nod1 and Nod2 are active in order to better understand their role in intestinal inflammation. We will use state of the art techniques to selectively block the expression of either Nod1 or Nod2 in a mouse for each cell type. These mice will then be subjected to either experimental intestinal inflammation or infection with an intestinal pathogen such as Salmonella typhimurium. By doing this, we will be able to better understand exactly what the functions Nod1 and Nod2 have in the intestine, how the loss of these functions can lead to IBD, and ultimately what we can do to target Nod1 and Nod2 function therapeutically to treat or cure patients with IBD.
Competitiondate
201110
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Prescott, David
Approvedterm
2 ans 0 mois
Cihrcontribution2
Inst of Nutr Metabolism &Diab~ $45,000~ $0~